MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura

[1]  M. Al-Haggar,et al.  Phenotype-genotype updates from familial Mediterranean fever database registry of Mansoura University Children’ Hospital, Mansoura, Egypt , 2014, Indian journal of human genetics.

[2]  A. Ensari,et al.  MEFV gene mutations in Henoch–Schönlein purpura , 2013, International journal of rheumatic diseases.

[3]  M. Koyun,et al.  Prevalence and significance of the MEFV gene mutations in childhood Henoch–Schönlein purpura without FMF symptoms , 2013, Rheumatology International.

[4]  Mohamed A Gomaa,et al.  The expanded clinical profile and the efficacy of colchicine therapy in Egyptian children suffering from familial mediterranean fever: a descriptive study , 2012, Italian Journal of Pediatrics.

[5]  M. Houshmand,et al.  MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with Henoch-Schönlein purpura. , 2012, Pneumologia.

[6]  H. El-Shanti,et al.  Spectrum of mutations and carrier frequency of familial Mediterranean fever gene in the Algerian population. , 2011, Rheumatology.

[7]  M. Bülbül,et al.  Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch–Schönlein purpura , 2011, Acta paediatrica.

[8]  K. Aksu,et al.  Coexistence of vasculitides with Familial Mediterranean Fever , 2011, Rheumatology International.

[9]  C. Heng,et al.  MEFV E148Q polymorphism is associated with Henoch–Schönlein purpura in Chinese children , 2010, Pediatric Nephrology.

[10]  A. Bakkaloğlu,et al.  EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.

[11]  A. Bagga,et al.  EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation , 2010, Annals of the rheumatic diseases.

[12]  D. Hashad,et al.  MEFV gene mutations in Egyptian patients with familial Mediterranean fever. , 2010, Genetic testing and molecular biomarkers.

[13]  M. Fawzy,et al.  Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterisation of the disease , 2010, British journal of biomedical science.

[14]  Sherif N. Amin,et al.  MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations , 2010, Rheumatology International.

[15]  F. Yalçınkaya,et al.  MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein Purpura , 2008, The Journal of Rheumatology.

[16]  A. Bakkaloğlu,et al.  Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. , 2007, The Journal of pediatrics.

[17]  M. Lidar,et al.  Familial Mediterranean fever: clinical, molecular and management advancements. , 2007, The Netherlands journal of medicine.

[18]  A. Settin,et al.  Clinical and molecular diagnosis of Familial Mediterranean Fever in Egyptian children. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[19]  F. Saulsbury.  Clinical update: Henoch-Schönlein purpura , 2007, The Lancet.

[20]  A. Mégarbané,et al.  Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. , 2006, European journal of medical genetics.

[21]  R. Gershoni-baruch,et al.  Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. , 2003, The Journal of pediatrics.

[22]  C. Cazeneuve,et al.  Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. , 2003, Clinical chemistry.

[23]  M. Tayeh,et al.  Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population. , 2003, Saudi medical journal.

[24]  A. Bakkaloğlu,et al.  Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? , 2003, The Journal of rheumatology.

[25]  M. Hiratsuka,et al.  Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. , 2002, British journal of clinical pharmacology.

[26]  F. Saulsbury.  Epidemiology of Henoch-Schönlein purpura. , 2002, Cleveland Clinic journal of medicine.

[27]  M. Tekin,et al.  Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever‐associated vasculitis , 2000, Acta paediatrica.